Specifically, NSCLC patients with a pre-treatment AST/ALT ratio exceeding 1.7 undergoing iRT treatment demonstrated a better prognosis compared to those with a lower AST/ALT ratio. Here, GPT is linked to non-small cell lung carcinoma.